- Home
- EQBK vs KURA Comparison
EQBK vs KURA Comparison
Compare EQBK & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQBK
- KURA
- Stock Information
- Founded
- EQBK 2002
- KURA 2014
- Country
- EQBK United States
- KURA United States
- Employees
- EQBK N/A
- KURA N/A
- Industry
- EQBK Major Banks
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EQBK Finance
- KURA Health Care
- Exchange
- EQBK Nasdaq
- KURA Nasdaq
- Market Cap
- EQBK 696.9M
- KURA 561.9M
- IPO Year
- EQBK 2015
- KURA N/A
- Fundamental
- Price
- EQBK $42.87
- KURA $6.44
- Analyst Decision
- EQBK Buy
- KURA Strong Buy
- Analyst Count
- EQBK 6
- KURA 12
- Target Price
- EQBK $44.40
- KURA $24.50
- AVG Volume (30 Days)
- EQBK 83.2K
- KURA 1.4M
- Earning Date
- EQBK 07-14-2025
- KURA 08-07-2025
- Dividend Yield
- EQBK 1.40%
- KURA N/A
- EPS Growth
- EQBK 543.37
- KURA N/A
- EPS
- EQBK 3.93
- KURA N/A
- Revenue
- EQBK $224,743,000.00
- KURA $67,991,000.00
- Revenue This Year
- EQBK $20.94
- KURA $125.04
- Revenue Next Year
- EQBK $10.08
- KURA $83.75
- P/E Ratio
- EQBK $10.92
- KURA N/A
- Revenue Growth
- EQBK 56.39
- KURA N/A
- 52 Week Low
- EQBK $32.95
- KURA $5.41
- 52 Week High
- EQBK $50.85
- KURA $23.48
- Technical
- Relative Strength Index (RSI)
- EQBK 63.84
- KURA 59.02
- Support Level
- EQBK $43.00
- KURA $5.65
- Resistance Level
- EQBK $44.32
- KURA $6.46
- Average True Range (ATR)
- EQBK 1.13
- KURA 0.26
- MACD
- EQBK 0.24
- KURA 0.07
- Stochastic Oscillator
- EQBK 73.71
- KURA 97.73
About EQBK Equity Bancshares Inc.
Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 71 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.